CA Corner

Kalind board sanctions up to five hundred crore rupees capital raise through shareholder rights issue

Originally reported by LiveMint Markets as: Multibagger penny stock: Kalind board approves fundraising plan, to raise up to ₹500 crore via rights issue

18 Nov 2026, 7:48 pm IST · Xecute.finance News DeskArchive edition

The crisp read

Kalind's board approved a fundraising plan to raise up to ₹500 crore via a rights issue for eligible shareholders. Details regarding the issue price, entitlement ratio, record date, and timeline remain pending.

Xecute Impact Breakdown

For CAs

  • Compliance teams must ensure client portfolios meet eligibility criteria if they intend to renounce or subscribe to the rights entitlement. Corporate advisors and investors should monitor upcoming company filings for the final record date, entitlement ratio, and pricing details.

For businesses

  • Kalind's board approved raising up to ₹500 crore through a rights issue for eligible shareholders, alongside auditor and joint company secretary appointments. The issue price, entitlement ratio, record date, and timeline are yet to be finalised.

Deep dive – the full story

Kalind’s board approved raising up to ₹500 crore through a rights issue for eligible shareholders, alongside auditor and joint company secretary appointments. The issue price, entitlement ratio, record date, and timeline are yet to be finalised. Rights issues allow listed companies to raise capital by offering existing shareholders additional shares in proportion to their current holdings at a specified price.

In practice, this mechanism enables companies to fund expansion plans or restructure capital without issuing fresh equity to external parties, shifting the shareholding structure based on shareholder participation. Corporate advisors and investors should monitor upcoming company filings for the final record date, entitlement ratio, and pricing details.

Compliance teams must ensure client portfolios meet eligibility criteria if they intend to renounce or subscribe to the rights entitlement. Bottom line: Track forthcoming company disclosures regarding pricing and timelines before making capital commitments to the rights issue.

Source: livemint.com

This is news/educational content, not investment advice. Xecute.finance is not SEBI-registered. Consult a qualified professional before acting.

More from the Xecute news desk

Reading the archive edition.

This story has retired from the live feed - the full text stays here permanently. The live app adds the newest desk, Ask Xecute, deadline trackers and the daily quiz.

Open this story in the Xecute app →